According to information procured exclusively a subsidiary of NYSE-traded giant Teva Pharmaceuticals has signed a deal with medical cannabis company Canndoc to distribute its GMP products to pharma customers.
As per the agreement, Teva subsidiary Salomon, Levin, Elstein will not only distribute Canndoc’s products in Israel, but also seek to “provide logistics capability for exporting Canndoc’s products to countries that support regulations for the sale and distribution of cannabis products for medical use,” as soon as local regulations allow for it, Canndoc, a subsidiary of publicly traded company InterCure, explained.
Adding to these notes, Canndoc’s Chairman Ehud Barak said, “Our agreement with S.L.E., Israel’s leading company in distributing medical products, creates a complete supporting platform for supplying Canndoc’s GMP products to any location in Israel and for countries with similar regulations… Through its S.L.E.
The initial agreement will span for three years, but a term to automatically extend it for two-year periods at a time is included in the deal.While this is not the first deal between a big pharma company and a cannabis-related business, it is among the couple notable ones to date – pharma is being careful with its approach to marijuana, hemp, CBD and related industries.The other big deal announced to date: a development and distribution deal between Novartis and Tilray.
Johnson & Johnson has also been getting its feet wet in the proverbial canna-pond. Back in 2017, the company’s incubator, JLABS @ Toronto,Beyond specific deals, a few big pharma companies have
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Exclusive: Purdue Pharma nears partial opioid settlement, bankruptcy filing - sourcesOxyContin maker Purdue Pharma LP is nearing a partial agreement to resolve wides...
Read more »
Exclusive: Purdue Pharma nears partial opioid settlement, bankruptcy filing - sourcesOxyContin maker Purdue Pharma LP is nearing a partial agreement to resolve wides...
Read more »
Aurora Cannabis pushes back profitability target to fiscal 2020Canadian company Aurora Cannabis Inc pushed back its profitability timeline to f...
Read more »
AB InBev set to revive Budweiser Asia IPO with $5 billion float: sourcesThe world's largest brewer, Anheuser-Busch InBev , which shelved a Hong Kon...
Read more »
The Sacklers tentatively agreed to pay $3 billion out of their pockets and dissolve Purdue Pharma to settle thousands of opioid lawsuitsPurdue Pharma will likely file for bankruptcy and be split into separate companies, two people involved in the negotiations told The Times.
Read more »
Purdue Pharma Settles Lawsuit Over Its Role In Opioid Crisis: ReportsPurdue Pharma has reportedly settled a consolidated federal lawsuit made up of more than 2,000 cities and counties accusing the OxyContin maker of being responsible for the country’s sweeping opioid crisis
Read more »